Neuroleptic malignant syndrome associated with olanzapine therapy: A case report

Journal of Emergency Medicine

Volumn 19, Issue 4, 2000, Pages 355-357

  Stanfield, Stephen C ^a,c   Privette, Troy ^b  

^a Lexington Medical Center   (United States)

^b Palmetto Richland Memorial Hospital   (United States)

^c NONE   (United States)

Author keywords

Antipsychotics; Hyperthermia; Neuroleptic Malignant Syndrome; Olanzapine; Zyprexa

Indexed keywords

DOPAMINE RECEPTOR; OLANZAPINE; SEROTONIN RECEPTOR;

ADULT; ARTICLE; CASE REPORT; EMERGENCY WARD; HUMAN; HYPERTHERMIA; MALE; NEUROLEPTIC MALIGNANT SYNDROME; PRIORITY JOURNAL; PRISON; SCHIZOPHRENIA; TREMOR;

ADULT; ANTI-BACTERIAL AGENTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BROMOCRIPTINE; COMBINED MODALITY THERAPY; CRYOTHERAPY; DANTROLENE; DOPAMINE AGONISTS; EMERGENCY TREATMENT; HEMIPLEGIA; HUMANS; INTUBATION, INTRATRACHEAL; MALE; MUSCLE RELAXANTS, CENTRAL; NEUROLEPTIC MALIGNANT SYNDROME; PIRENZEPINE; SCHIZOPHRENIA; SEROTONIN UPTAKE INHIBITORS;

EID: 0033765444     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-4679(00)00263-8     Document Type: Article

References (7)

1. Neuroleptic malignant syndrome associated with olanzapine
2. Neuroleptic malignant syndrome
3. Risk Factors for neuroleptic malignant syndrome
4. Olanzapine; a serotonin-dopamine-receptor antagonist for antipsychotic therapy
5. Pharmacodynamic and pharmacokinetic factors in a case of neuroleptic malignant syndrome
6. Neuroleptic malignant syndrome; controversies in treatment
7. Risperidone induced neuroleptic malignant syndrome